Cargando…

Platelet-to-lymphocyte ratio is an independent predictor of chemoradiotherapy-related esophageal fistula in esophageal cancer patients

BACKGROUND: Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) are all markers of systemic inflammation response. The role of systemic inflammation in the development of esophageal fistula (EF) has yet to be defined. This study aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Dong, Zhang, Jiajia, Zhao, Jingjing, Lei, Tongda, Chen, Xi, Zhang, Tian, Wei, Hui, Guan, Yong, Wang, Jing, Zhang, Wencheng, Zhao, Lujun, Wang, Jun, Yuan, Zhiyong, Song, Yongchun, Liu, Ningbo, Pang, Qingsong, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576074/ https://www.ncbi.nlm.nih.gov/pubmed/33241012 http://dx.doi.org/10.21037/atm-20-4053

Ejemplares similares

Baseline nutritional status could be a predictor for radiation esophagitis in esophageal cancer patients undergoing radiotherapy
por: Dong, Jie, et al.
Publicado: (2020)

Predictive value of EGF and uPAR for chemoradiotherapy response and survival in patients with esophageal squamous cell carcinoma
por: Chen, Xi, et al.
Publicado: (2020)

Prognostic value of supraclavicular nodes and upper abdominal nodes metastasis after definitive chemoradiotherapy for patients with thoracic esophageal squamous cell carcinoma
por: Li, Xue, et al.
Publicado: (2017)

Annual report of the esophageal cancer radiation group of the Department of Radiotherapy, Tianjin Medical University Cancer Institute & Hospital
por: Pang, Qingsong, et al.
Publicado: (2020)

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Jingjing, et al.
Publicado: (2020)

Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade
por: Ma, Xiaoxue, et al.
Publicado: (2022)

Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor
por: Zhao, Jingjing, et al.
Publicado: (2020)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
por: Li, Yang, et al.
Publicado: (2021)

Clinical results of intensity-modulated radiotherapy for 250 patients with cervical and upper thoracic esophageal carcinoma
por: Zhang, Jiaqi, et al.
Publicado: (2019)

Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis
por: Zhao, Qing-Tao, et al.
Publicado: (2017)

Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy
por: Zhang, Yang, et al.
Publicado: (2018)

Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2022)

A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy
por: Zhang, Tian, et al.
Publicado: (2022)

Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review
por: Zhang, Wencheng, et al.
Publicado: (2020)

Elevated Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio after First Cycle of Chemotherapy and Better Survival in Esophageal Cancer Patients Receiving Concurrent Chemoradiotherapy
por: Tseng, Ruo-Han, et al.
Publicado: (2022)

Chemoradiotherapy-Induced CD4(+) and CD8(+) T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma
por: Chen, Xi, et al.
Publicado: (2019)

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2021)

Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study
por: Zhang, Wencheng, et al.
Publicado: (2021)

Predictive Value of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Monocyte-to-Lymphocyte Ratio Esophageal Stricture After Endoscopic Submucosal Dissection of Early Esophageal Cancer
por: Liu, Shasha, et al.
Publicado: (2023)

Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer
por: Wu, Rong, et al.
Publicado: (2020)

Thoracoscopy for Esophageal Diverticula After Esophageal Atresia With Tracheo-Esophageal Fistula
por: Yong, Zhao, et al.
Publicado: (2021)

NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc
por: Wang, Yuwen, et al.
Publicado: (2018)

Baseline FDG Uptake And Peripheral Lymphocyte-Monocyte Ratio For Predicting Chemoradiotherapy Response In Patients With Esophageal Squamous Cell Carcinoma
por: Wang, Chunsheng, et al.
Publicado: (2019)

Correlation between neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and postoperative cognitive dysfunction in elderly patients with esophageal cancer
por: Zhao, Jie, et al.
Publicado: (2023)

Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer
por: Yan, Cihui, et al.
Publicado: (2023)

The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
por: Liu, Xuemei, et al.
Publicado: (2017)

The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy
por: Er, Puchun, et al.
Publicado: (2020)

Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy
por: Shi, Yan-Jie, et al.
Publicado: (2022)

Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Wang, Jianing, et al.
Publicado: (2021)

Impact of Platelets to Lymphocytes Ratio and Lymphocytes during Radical Concurrent Radiotherapy and Chemotherapy on Patients with Nonmetastatic Esophageal Squamous Cell Carcinoma
por: Zhang, Yaotian, et al.
Publicado: (2022)

Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2017)

Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis
por: Zhang, Xiangwei, et al.
Publicado: (2018)

The Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Predicts Disease-Free Survival in Resectable Esophageal Squamous Cell Carcinoma
por: Zheng, Zhiwei, et al.
Publicado: (2021)

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
por: Song, Xinyu, et al.
Publicado: (2018)

XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma
por: Cheng, Jingjing, et al.
Publicado: (2015)

Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
por: Liu, Maoxi, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
por: Zhou, Xi-Lei, et al.
Publicado: (2017)

Esophageal atresia with tracheo-esophageal fistula
por: Chatterjee, Subir K.
Publicado: (2010)

Programmed death‐ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor
por: Zhang, Wencheng, et al.
Publicado: (2017)

Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis
por: Fan, Ningbo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jijekst9n6sv6dlccpugjanh0n